https://de.marketscreener.com/kurs/aktie/SPEXIS-AG-43371335/news/EQS-Adhoc-Polyphor-gibt-abschliessendes-Update-zur-Phase-III-Studie-FORTRESS-mit-Balixafortide-bei-36055579/?utm_source=telegram&utm_medium=social&utm_campaign=share